Back to search

Article

Genome-wide functional genomics screens identify therapeutic vulnerabilities for lymphangioleiomyomatosis

2019-06-27

Abstract excerpt

Lymphangioleiomyomatosis (LAM) is a rare lung disease marked by cystic destruction caused by invasive LAM cells harboring loss-of-function mutations in TSC2 that exhibit dysregulated mTORC1 signaling. Rapamycin, the only approved treatment, is not curative. Therapeutic discovery has been limited by inadequate cell and animal models due to the unknown LAM cell of origin. We report a novel TSC2 —/— human pluripot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a795ebf-2c3a-57e0-80e8-7d9d32ad9227
DOI
10.1101/683359
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genome-wide functional genomics screens identify therapeutic vulnerabilities for lymphangioleiomyomatosisDOI 10.1101/683359
Select a neighboring publication to make it the new centre.